The introduction of biologic agents such as tumor necrosis factor-alpha (TNF-α)antibodies and interferon alpha (IFN-α) provides a new intervention regimen forpatients with refractory uveitis [3], [4], [5]. This evidence concerns the gene TNF and uveitis.